Kim SW, Baik SH, Yoon KH, Lee HW, Filozof C. Efficacy and safety of vildagliptin/pioglitazone combination therapy in Korean patients with diabetes. World J Diabetes 2010; 1(5): 153-160 [PMID: 21537443 DOI: 10.4239/wjd.v1.i5.153]
Corresponding Author of This Article
Claudia Filozof, MD, PhD, Principal Medical Scientific Expert, Novartis Pharma AG, Postfach, Basel, CH-4002, Switzerland. claudia.filozof@novartis.com
Article-Type of This Article
Brief Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/